EPIGESIC

This brand name is authorized in Nigeria.

Active ingredients

The drug EPIGESIC contains a combination of these active pharmaceutical ingredients (APIs):

1	Orphenadrine UNII X0A40N8I4S - ORPHENADRINE CITRATE
	Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism.
	Read more about Orphenadrine
2	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0008	Tablet	EPIGESIC TABLETS TAB 35 mg; 450 mg 2 X 10	47 RNW-PP-177793 EPIGESIC TABLETS Orphenasrine Citrate 35mg + Paracetamol 450mg Orphenadrine citrate 35mg + Paracetamol 450mg, starch. A4-0008 Drugs MUSCULO-SKELETAL SYSTEM Imported Products 2 x 10's Prescription Only Medicine (POM) 11/3/2020 C' D - DEMERIS PHARMACEUTICALS LIMITED, AKINSANYA STREET, OJODU. LAGOS 8032069197 cdemerispharma@yahoo.co.uk Egyptian International Pharmaceutical Industries Co. (EIPICO)., 10th of Ramadan City, Industrial Zone B1, Cairo, Egypt., Egypt	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03BC51	Orphenadrine, combinations	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BC Ethers, chemically close to antihistamines
Discover more medicines within M03BC51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0008